Oprm1tm2.1Loh
Targeted Allele Detail
|
|
| Symbol: |
Oprm1tm2.1Loh |
| Name: |
opioid receptor, mu 1; targeted mutation 2.1, Horace H Loh |
| MGI ID: |
MGI:2651420 |
| Synonyms: |
S196A |
| Gene: |
Oprm1 Location: Chr10:6708593-6988209 bp, + strand Genetic Position: Chr10, 1.85 cM, cytoband A2
|
| Alliance: |
Oprm1tm2.1Loh page
|
|
| Germline Transmission: |
Earliest citation of germline transmission:
J:81978
|
| Parent Cell Line: |
Other (see notes) (ES Cell)
|
| Strain of Origin: |
Not Specified
|
|
| Allele Type: |
|
Targeted |
| Mutation: |
|
Nucleotide substitutions
|
| |
|
Mutation details: The intronic neo cassette was excised from Oprmtm2Loh via in vivo cre mediated recombination, leaving the engineered serine to alanine missense mutation in exon 2 at codon 196 (S196A) intact. S196A affects the fourth transmembrane domain. A radioactive ligand receptor-binding assay showed reduced expression of the mutant protein in homozygous mutant mice, approximately 85% that of the endogenous protein in wild-type mice. The reduced protein expression correlated with reduced levels of transcript.
(J:81978)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Oprm1 Mutation: |
55 strains or lines available
|
|
|
|
| Original: |
J:81978 Yang W, et al., In vivo activation of a mutant mu-opioid receptor by antagonist: future direction for opiate pain treatment paradigm that lacks undesirable side effects. Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):2117-21 |
| All: |
2 reference(s) |
|